Literature DB >> 15904433

Clinical variability in a Japanese hereditary lymphedema type I family with an FLT4 mutation.

Seiji Mizuno1, Yasukazu Yamada, Kenichiro Yamada, Noriko Nomura, Nobuaki Wakamatsu.   

Abstract

Hereditary lymphedema type I (Milroy disease) is a rare autosomal dominant disease resulting from mutations of FLT4 encoding the vascular endothelial growth factor receptor-3. Patients develop edema of the legs and feet, resulting in chronic swelling of the lower extremities from the neonatal period. Here we report a Japanese family with 10 affected members of five generations of hereditary lymphedema type I. We identified a previously reported missense mutation of G857R in one allele of FLT4 from three affected individuals of three generations, the mother of whom presented only hemi-lymphedema of the left foot. Thus, the clinical features of hereditary lymphedema type I caused by a FLT4 mutation are heterogeneous and it would be appropriate to consider FLT4 mutations even in a patient with hemi-lymphedema of the foot.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15904433     DOI: 10.1111/j.1741-4520.2005.00064.x

Source DB:  PubMed          Journal:  Congenit Anom (Kyoto)        ISSN: 0914-3505            Impact factor:   1.409


  2 in total

1.  Prioritization of genes involved in endothelial cell apoptosis by their implication in lymphedema using an analysis of associative gene networks with ANDSystem.

Authors:  Olga V Saik; Vadim V Nimaev; Dilovarkhuja B Usmonov; Pavel S Demenkov; Timofey V Ivanisenko; Inna N Lavrik; Vladimir A Ivanisenko
Journal:  BMC Med Genomics       Date:  2019-03-13       Impact factor: 3.063

2.  A family with Milroy disease caused by the FLT4/VEGFR3 gene variant c.2774 T > A.

Authors:  Yu Sui; Yongping Lu; Meina Lin; Xiang Ni; Xinren Chen; Huan Li; Miao Jiang
Journal:  BMC Med Genomics       Date:  2021-06-08       Impact factor: 3.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.